Phase I trial of escalting doses of 4-hydroxycyclophosphamide (4HC) purged autologous peripheral blood progenitor cells (PBPC) for leukemia.
Publication
, Journal Article
Rizzieri, DA; Long, GD; Gasparetto, C; Smith, CS; Vredenburgh, JJ; Morris, AK; Petros, WP; Loftis, J; McDonald, CS; Waters-Pick, B; Adams, DJ ...
Published in: BLOOD
November 16, 2000
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2000
Volume
96
Issue
11
Start / End Page
385A / 385A
Publisher
AMER SOC HEMATOLOGY
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Rizzieri, D. A., Long, G. D., Gasparetto, C., Smith, C. S., Vredenburgh, J. J., Morris, A. K., … Chao, N. J. (2000). Phase I trial of escalting doses of 4-hydroxycyclophosphamide (4HC) purged autologous peripheral blood progenitor cells (PBPC) for leukemia. BLOOD, 96(11), 385A-385A.
Rizzieri, D. A., G. D. Long, C. Gasparetto, C. S. Smith, J. J. Vredenburgh, A. K. Morris, W. P. Petros, et al. “Phase I trial of escalting doses of 4-hydroxycyclophosphamide (4HC) purged autologous peripheral blood progenitor cells (PBPC) for leukemia.” BLOOD 96, no. 11 (November 16, 2000): 385A-385A.
Rizzieri DA, Long GD, Gasparetto C, Smith CS, Vredenburgh JJ, Morris AK, et al. Phase I trial of escalting doses of 4-hydroxycyclophosphamide (4HC) purged autologous peripheral blood progenitor cells (PBPC) for leukemia. BLOOD. 2000 Nov 16;96(11):385A-385A.
Rizzieri, D. A., et al. “Phase I trial of escalting doses of 4-hydroxycyclophosphamide (4HC) purged autologous peripheral blood progenitor cells (PBPC) for leukemia.” BLOOD, vol. 96, no. 11, AMER SOC HEMATOLOGY, Nov. 2000, pp. 385A-385A.
Rizzieri DA, Long GD, Gasparetto C, Smith CS, Vredenburgh JJ, Morris AK, Petros WP, Loftis J, McDonald CS, Waters-Pick B, Adams DJ, Chao NJ. Phase I trial of escalting doses of 4-hydroxycyclophosphamide (4HC) purged autologous peripheral blood progenitor cells (PBPC) for leukemia. BLOOD. AMER SOC HEMATOLOGY; 2000 Nov 16;96(11):385A-385A.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2000
Volume
96
Issue
11
Start / End Page
385A / 385A
Publisher
AMER SOC HEMATOLOGY
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology